Simcere Pharmaceutical Group Limited(HK:2096)
HK$10.42-0.08 (-0.76%)
HK:2096
Simcere Pharmaceutical Group Limited financials statements
HK$10.42
At close:-0.08 (-0.76%)
Want to see HK:2096 full AI Analyst Report?
Simcere Pharmaceutical Group Limited (2096) Income Statement
4 Followers
Simcere Pharmaceutical Group Limited Income Statement
Last quarter (Q2 2026), Simcere Pharmaceutical Group Limited's total revenue was ¥4.52B, an increase of 45.07% from the same quarter last year. In Q2, Simcere Pharmaceutical Group Limited's net income was ¥817.28M. See Simcere Pharmaceutical Group Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 7.73B | ¥ 6.64B | ¥ 6.61B | ¥ 6.32B | ¥ 5.00B | |
| ¥ 6.31B | ¥ 5.32B | ¥ 4.98B | ¥ 5.00B | ¥ 3.92B | |
| ¥ 4.75B | ¥ 4.48B | ¥ 4.27B | ¥ 4.14B | ¥ 2.47B | |
| Depreciation and Amortization | ¥ 380.83M | ¥ 337.86M | ¥ 309.59M | ¥ 283.65M | ¥ 251.81M |
| ¥ 1.80B | ¥ 1.47B | ¥ 1.08B | ¥ 889.99M | ¥ 485.14M | |
| ¥ 1.56B | ¥ 848.05M | ¥ 711.80M | ¥ 862.50M | ¥ 1.45B | |
| ¥ -41.16M | ¥ -28.17M | ¥ 28.24M | ¥ 25.65M | ¥ -46.75M | |
| ¥ 1.51B | ¥ 819.88M | ¥ 740.04M | ¥ 888.15M | ¥ 1.40B | |
| ¥ 1.34B | ¥ 733.16M | ¥ 714.76M | ¥ 930.87M | ¥ 1.51B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 0.54 | ¥ 0.29 | ¥ 0.27 | ¥ 0.36 | ¥ 0.58 |
| Diluted EPS | ¥ 0.54 | ¥ 0.29 | ¥ 0.27 | ¥ 0.36 | ¥ 0.58 |
| Weighted Average Shares Outstanding | 2.49B | 2.52B | 2.61B | 2.61B | 2.61B |
| Weighted Average Shares Outstanding (Diluted) | 2.49B | 2.52B | 2.61B | 2.62B | 2.61B |
Currency in CNY

